Oncology Pharma (OTCMKTS:ONPH – Get Rating) and Zenvia (NASDAQ:ZENV – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.
This table compares Oncology Pharma and Zenvia’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
55.0% of Zenvia shares are held by institutional investors. 18.0% of Oncology Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Oncology Pharma and Zenvia’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Zenvia||$113.49 million||1.61||-$8.27 million||($0.26)||-17.08|
Oncology Pharma has higher earnings, but lower revenue than Zenvia.
This is a summary of current ratings and recommmendations for Oncology Pharma and Zenvia, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Zenvia has a consensus target price of $21.15, suggesting a potential upside of 376.35%. Given Zenvia’s higher possible upside, analysts clearly believe Zenvia is more favorable than Oncology Pharma.
Oncology Pharma Company Profile (Get Rating)
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
Zenvia Company Profile (Get Rating)
Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.
Receive News & Ratings for Oncology Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Pharma and related companies with MarketBeat.com's FREE daily email newsletter.